DIAGNOPLEX

diagnoplex-logo

Diagnoplex has been founded in 2005 supported by seed financing fron the Novartis Forschungsstiftung, Swiss Confederation CTI project, Canton de Vaud FIT and the Gebert Rรƒยผf Stiftung. The company has performed a 140 patient prospective pilot study demonstrating technical and clinical feasibility of its colorectal cancer screening test COLOX as well as its high sensitivity and specificity.

#SimilarOrganizations #People #Financial #Website #More

DIAGNOPLEX

Social Links:

Industry:
Biotechnology Medical Device

Founded:
2005-01-01

Address:
Lausanne, Vaud, Switzerland

Country:
Switzerland

Website Url:
http://www.diagnoplex.com

Total Employee:
1+

Status:
Active

Contact:
+41 21 989 20 00

Email Addresses:
[email protected]

Total Funding:
9.85 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon GoDaddy DNS OpenResty Google Adsense AdBlock Acceptable Ads Google Adsense For Domains


Similar Organizations

illumina-logo

Illumina

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

tarsa-therapeutics-logo

Tarsa Therapeutics

Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.


Current Advisors List

anja-kรถnig_image

Anja Kรถnig Board Positions @ Diagnoplex
Board_member

Current Employees Featured

not_available_image

Stavros Therianos
Stavros Therianos Founder & CEO @ Diagnoplex
Founder & CEO

Founder


not_available_image

Stavros Therianos

Investors List

initiative-capital-romandie_image

Initiative Capital Romandie

Initiative Capital Romandie investment in Venture Round - Diagnoplex

debiopharm-innovation-fund_image

Debiopharm Innovation Fund

Debiopharm Innovation Fund investment in Venture Round - Diagnoplex

neomed-management_image

Neomed Management

Neomed Management investment in Venture Round - Diagnoplex

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series A - Diagnoplex

neomed-management_image

Neomed Management

Neomed Management investment in Series A - Diagnoplex

foundation-pour-l-innovation-technologique_image

Foundation for Technological Innovation (FIT)

Foundation for Technological Innovation (FIT) investment in Debt Financing - Diagnoplex

Official Site Inspections

http://www.diagnoplex.com

  • Host name: a2b7bf3398455f345.awsglobalaccelerator.com
  • IP address: 99.83.161.153
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Diagnoplex"

Diagnoplex - Crunchbase Company Profile & Funding

Diagnoplex has been founded in 2005 supported by seed financing fron the Novartis Forschungsstiftung, Swiss Confederation CTI project, Canton de Vaud FIT and the Gebert โ€ฆSee details»

Diagnoplex - Company Profile - Tracxn

Feb 20, 2025 Diagnoplex - Molecular diagnostics for colorectal cancer.. Acquired by Novigenix. Raised a total funding of $9.68M over 3 rounds from 4 investors. Founded by Stavros โ€ฆSee details»

Diagnoplex - VentureRadar

Diagnoplex is a molecular diagnostics company with the objective of developing and commercializing a portfolio of tests for the early detection of various cancers. Diagnoplexโ€™s โ€ฆSee details»

Diagnoplex SA - Company Profile and News - Bloomberg Markets

Company profile page for Diagnoplex SA including stock price, company news, executives, board members, and contact informationSee details»

Diagnoplex - Raised $9.68M Funding from 4 investors - Tracxn

Mar 9, 2025 Diagnoplex has raised a total funding of $9.68M over 3 rounds from 4 investors. Investors include Novartis Venture Fund, NeoMed and 2 others. Their latest funding round โ€ฆSee details»

Diagnoplex - Products, Competitors, Financials, Employees, โ€ฆ

Diagnoplex's lead product, Colox, is a convenient and minimally-invasive blood test developed for the systematic screening of colorectal cancer. The gene signature underlying Colox has been โ€ฆSee details»

Curzio Ruegg โ€“ Chief Executive Officer โ€“ Xemperia | LinkedIn

He is member of numerous national and international scientific committees and advisory boards (eg. SNSF, DFG, INSERM, SKL, CRUK, UICC, IARC, BIOS+,โ€ฆ) and member of the Senate โ€ฆSee details»

DIAGNOPLEX Trademark - Registration Number 4427038 - Serial โ€ฆ

Blood for medical purposes; blood plasma; reagents for medical or veterinary use. Measuring and checking apparatus and instruments, namely, thermocyclers, for DNA and RNA quantification; โ€ฆSee details»

Diagnoplex S.A. - BioCentury Company Profiles - BCIQ

Diagnoplex S.A. - BioCentury Company Profiles for the biopharma industrySee details»

Diagnoplex SA | Insights

Nov 6, 2013 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

Diagnoplex Closes a Financing Round Led by Debiopharm โ€ฆ

Jun 7, 2013 Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Diagnostics SA, part of the Swiss-based global biopharmaceutical group of โ€ฆSee details»

Diagnoplex and Unilabs sign agreement to market colon cancer โ€ฆ

Register and get more services Create your personal archive Get the Newsletter Set award alarms. Get involvedSee details»

News - University of Fribourg - Colon cancer: new screening test

Researchers at the University of Fribourg have developed a test enabling the early detection of colorectal cancer by means of a blood test. The test was developed in collaboration with โ€ฆSee details»

Novartis Services Inc investment in Diagnoplex Sarl ()

Add your company. If your company is not in the database, create an account and, once logged in, add it by selecting "Add" > "Add company" in order to create a profile.See details»

Unilabs and Diagnoplex SA Announce the Swiss Market Launch of โ€ฆ

Feb 28, 2014 Unilabs, a leading supplier of clinical laboratory and medical diagnostic imaging services in Europe and Diagnoplex SA, a developer of molecular diagnostics for colorectal โ€ฆSee details»

(PDF) Organizational Diagnosis: An Evidence-based Approach

Jan 1, 2012 Organizational diagnosis plays a critical role in organizational change initiatives in terms of both choosing appropriate interventions and contributing to readiness-to-change โ€ฆSee details»

Organizational Diagnostic & Employee Wellbeing Solutions

Work in an organization that prioritizes employee success and mental health. Provide Feedback That Matters. Employee insights shape real organizational changeโ€”your input drives action. โ€ฆSee details»

Expert Cancer Detection | Previse

Esophageal cancer is a global concern. In 2025, an estimated 22,070 people will be diagnosed with esophageal cancer in the United States and about 16,250 people will die from the disease โ€ฆSee details»

Category : Music Files (Naming and Organizing) | Plex Support

Plex and our partners use standard Web technologies, such as browser cookies, which may be necessary to make our site work and enable core functionality, such as security, network โ€ฆSee details»

Tag support for ROBUST music library organization

Jun 16, 2015 This is a request for comprehensive support of the ID3/Vorbis/etc. tags that are necessary for truly meaningful and complete organization of music libraries, both classical and โ€ฆSee details»

linkstock.net © 2022. All rights reserved